Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanotech Boom Presents Challenges For Both Industry, Regulators

This article was originally published in The Tan Sheet

Executive Summary

FDA says it stands ready to shepherd the nanotech industry into producing safe and effective nanotech-based OTC drugs, cosmetics and other products despite gaps that exist in its ability to regulate the technology as it develops
Advertisement

Related Content

Nanotech Experts Question Whether Regulatory “Gaps” Affect Consumers
FDA Nanotechnology Oversight Limited By Budget Constraints – Report
Task Force To Develop Approaches To Nanotechnology In Drugs, Foods
Task Force To Develop Approaches To Nanotechnology In Drugs, Foods

Topics

Advertisement
UsernamePublicRestriction

Register

PS099852

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel